New indolin-2-ones, possessing sunitinib scaffold as HDAC inhibitors and anti-cancer agents with potential VEGFR inhibition activity; design, synthesis and biological evaluation

Mozhdeh Yousefian(Mashhad University of Medical Sciences), Razieh Ghodsi(Biotechnology Research Center), Maryam Hashemi(University of Kashan), Vahid Eskandarpour(Mashhad University of Medical Sciences), Farzin Hadizadeh(Mashhad University of Medical Sciences), Afshin Zarghi(Shahid Beheshti University of Medical Sciences)
Bioorganic Chemistry
January 30, 2025
Cited by 16


Related Papers